Back to Trades
Other4
Structure Therapeutics Inc.
GPCR
Total Value
$0
Company Information
- Company Name
- Structure Therapeutics Inc.
- Ticker Symbol
- GPCR
- CIK
- 0001888886
Insider Information
- Name
- FMR LLC
- Role
- Insider
- Location
- BOSTON, MA
Filing Details
- Filing Date
- Jan 20, 2026
- Transaction Date
- Jan 15, 2026
- Accession Number
- 0001193125-26-016062
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jan 15, 2026 | Derivative | 465 | — | Sale | — |
| Jan 15, 2026 | Derivative | 330 | — | Sale | — |
| Jan 15, 2026 | Derivative | 552 | — | Sale | — |
| Jan 15, 2026 | Derivative | 20 | — | Sale | — |
| Jan 15, 2026 | Derivative | 5,477 | — | Sale | — |
| Jan 15, 2026 | Derivative | 3,880 | — | Sale | — |
| Jan 15, 2026 | Derivative | 6,498 | — | Sale | — |
| Jan 15, 2026 | Derivative | 230 | — | Sale | — |
Footnotes
- (F1)Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer.
- (F2)The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $82.00 to $82.37. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information
- (F3)The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $83.00 to $83.84. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information
- (F4)The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $84.00 to $84.64. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information
- (F5)The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $85.02 to $85.06. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information